• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?

作者信息

Barzilay Joshua I, Whelton Paul K, Davis Barry R

机构信息

1 Kaiser Permanente of Georgia and the Division of Endocrinology, Emory University School of Medicine, Atlanta, GA, USA ; 2 Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA ; 3 Department of Biostatistics, University of Texas School of Public Health, Houston, TX, USA.

出版信息

Ann Transl Med. 2016 May;4(10):202. doi: 10.21037/atm.2016.05.24.

DOI:10.21037/atm.2016.05.24
PMID:27294098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4885898/
Abstract
摘要

相似文献

1
Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?在治疗糖尿病患者时，肾素-血管紧张素系统阻断剂相对于其他抗高血压药物而言，是否值得享有优先地位？
Ann Transl Med. 2016 May;4(10):202. doi: 10.21037/atm.2016.05.24.
2
Blood pressure and proteinuria after cessation of a brief renin-angiotensin system blockade in young and adult Lyon hypertensive rats.年轻和成年里昂高血压大鼠短暂肾素-血管紧张素系统阻断停止后的血压和蛋白尿
J Cardiovasc Pharmacol. 2005 Dec;46(6):740-5. doi: 10.1097/01.fjc.0000185784.77520.04.
3
Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.β-肾上腺素能受体阻滞剂作为一种治疗方法，用于抑制血压正常和高血压受试者的肾素-血管紧张素-醛固酮系统。
Am J Hypertens. 1999 May;12(5):451-9. doi: 10.1016/s0895-7061(99)00005-9.
4
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.糖尿病肾病中肾素-血管紧张素系统的单药与联合阻断治疗（血管紧张素转换酶抑制剂和/或血管紧张素II受体阻滞剂）
Curr Opin Nephrol Hypertens. 2004 May;13(3):319-24. doi: 10.1097/00041552-200405000-00009.
5
Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.双重钙通道及肾素-血管紧张素系统阻断对高血压血管疾病的靶向作用机制
J Hum Hypertens. 2007 Oct;21(10):770-9. doi: 10.1038/sj.jhh.1002254. Epub 2007 Jun 28.
6
Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.在已患慢性肾脏病的5/6肾切除的Ren-2转基因高血压大鼠中，可溶性环氧化物水解酶和肾素-血管紧张素系统联合抑制对肾脏的保护作用优于肾素-血管紧张素系统阻断。
Kidney Blood Press Res. 2018;43(2):329-349. doi: 10.1159/000487902. Epub 2018 Mar 6.
7
Renin-angiotensin system blockade alone or combined with ET receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.单独或联合使用肾素-血管紧张素系统阻断和内皮素受体阻断对 5/6 肾切除 Ren-2 转基因高血压大鼠慢性肾脏病病程的影响。
Clin Exp Hypertens. 2017;39(2):183-195. doi: 10.1080/10641963.2016.1235184. Epub 2017 Mar 1.
8
Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.糖尿病自发性高血压大鼠的心血管肥大：优化肾素-血管紧张素系统阻断
Clin Sci (Lond). 2003 Apr;104(4):341-7.
9
Comparative effects of three sites of renin-angiotensin blockade on the regression of left ventricular hypertrophy in spontaneously hypertensive rats.肾素-血管紧张素阻断的三个位点对自发性高血压大鼠左心室肥厚消退的比较作用。
Am J Ther. 1997 May-Jun;4(5-6):199-202. doi: 10.1097/00045391-199705000-00006.
10
Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study.肥胖、肾素-血管紧张素系统阻断与不良肾脏结局风险：一项基于人群的队列研究。
Am J Nephrol. 2016;43(6):431-40. doi: 10.1159/000446862. Epub 2016 May 28.

引用本文的文献

1
Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!肾素-血管紧张素-醛固酮系统调节在糖尿病肾病中的潜力：旧有靶点带来新希望！
Rev Physiol Biochem Pharmacol. 2021;179:31-71. doi: 10.1007/112_2020_50.
2
Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.替米沙坦与七叶亭联合使用通过逆转H3、H2A和H2B组蛋白修饰改善2型糖尿病性心肌病。
Indian J Pharmacol. 2017 Sep-Oct;49(5):348-356. doi: 10.4103/ijp.IJP_710_16.
3
The relentless crumbling of the renin-angiotensin system (RAS)-blockade halo.肾素-血管紧张素系统（RAS）阻断光环的持续破灭。
Ann Transl Med. 2016 Aug;4(16):321. doi: 10.21037/atm.2016.08.11.

本文引用的文献

1
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials.糖尿病作为使用肾素血管紧张素系统阻滞剂的有力指征：随机试验的系统评价和荟萃分析
BMJ. 2016 Feb 11;352:i438. doi: 10.1136/bmj.i438.
2
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.美国临床内分泌医师协会和美国内分泌学会关于2型糖尿病综合管理算法的共识声明——2016年执行摘要
Endocr Pract. 2016 Jan;22(1):84-113. doi: 10.4158/EP151126.CS.
3
(8) Cardiovascular disease and risk management.（8）心血管疾病与风险管理。
Diabetes Care. 2015 Jan;38 Suppl:S49-57. doi: 10.2337/dc15-S011.
4
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).2014 年成人高血压管理的循证指南：第八届联合国家委员会（JNC 8）任命的专家组报告。
JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427.
5
Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study.替米沙坦对无糖尿病心血管疾病高危人群血糖水平的影响：TRANSCEND 研究。
Diabetes Care. 2011 Sep;34(9):1902-7. doi: 10.2337/dc11-0545. Epub 2011 Jul 25.
6
RAS blockade for every diabetic patient: pro and con.对每位糖尿病患者进行肾素-血管紧张素系统（RAS）阻断：利弊分析
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S320-4. doi: 10.2337/dc11-s248.
7
Effect of valsartan on the incidence of diabetes and cardiovascular events.缬沙坦对糖尿病和心血管事件发生的影响。
N Engl J Med. 2010 Apr 22;362(16):1477-90. doi: 10.1056/NEJMoa1001121. Epub 2010 Mar 14.
8
Renal and retinal effects of enalapril and losartan in type 1 diabetes.依那普利和氯沙坦对1型糖尿病患者肾脏和视网膜的影响
N Engl J Med. 2009 Jul 2;361(1):40-51. doi: 10.1056/NEJMoa0808400.
9
Telmisartan, ramipril, or both in patients at high risk for vascular events.替米沙坦、雷米普利或两者联合用于血管事件高危患者。
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
10
Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.一项关于儿童期发病的1型糖尿病队列中微量白蛋白尿及进展为大量白蛋白尿风险的前瞻性观察研究。
BMJ. 2008 Mar 29;336(7646):697-701. doi: 10.1136/bmj.39478.378241.BE. Epub 2008 Mar 18.